Genetic polymorphisms in ADH1B and/or ALDH2 can result in different enzymatic activities that have a major impact on the risk of ESCC as well as head and neck squamous cell carcinoma (HNSCC) [13,14,15,16]. The gene discussed is ADH1B; the disease is esophageal squamous cell carcinoma.